Large-scale testing (Phase 3)Study completedNCT00341328
What this trial is testing
Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.
Who this might be right for
Tuberculosis
Ministry of Science and Technology, India 300